The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Deficiency of the type I interferon receptor protects mice from experimental lupus
Open accessAbstract
Objective: Systemic lupus erythematosus (SLE) is diagnosed according to a spectrum of clinical manifestations and autoantibodies associated with abnormal expression of type I interferon (IFN‐I)–stimulated genes (ISGs). The role of IFN‐I in the pathogenesis of SLE remains uncertain, partly due to the lack of suitable animal models. The objective of this study was to examine the role of IFN‐I signaling in the pathogenesis of murine lupus induced by 2,6,10,14‐tetramethylpentadecane (TMPD). Methods: IFN‐I receptor–deficient (IFNAR−/−) 129Sv mice and wild‐type (WT) 129Sv control mice were treated intraperitoneally with TMPD. The expression of ISGs was measured by real‐time polymerase chain reaction. Autoantibody production was evaluated by immunofluorescence and enzyme‐linked immunosorbent assay. Proteinuria and renal glomerular cellularity were measured and renal immune complexes were examined by immunofluorescence. Results: Increased ISG expression was observed in the peripheral blood of TMPD‐treated WT mice, but not in the peripheral blood of TMPD‐treated IFNAR−/− mice. TMPD did not induce lupus‐specific autoantibodies (anti‐RNP, anti‐Sm, anti–double‐stranded DNA) in IFNAR−/− mice, whereas 129Sv controls developed these specificities. Although glomerular immune complexes were present in IFNAR−/− mice, proteinuria and glomerular hypercellularity did not develop, whereas these features of glomerulonephritis were found in the TMPD‐treated WT controls. The clinical and serologic manifestations observed in TMPD‐treated mice were strongly dependent on IFNAR signaling, which is consistent with the association of increased expression of ISGs with lupus‐specific autoantibodies and nephritis in humans. Conclusion: Similar to its proposed role in human SLE, signaling via the IFNAR is central to the pathogenesis of autoantibodies and glomerulonephritis in TMPD‐induced lupus. This lupus model is the first animal model shown to recapitulate the “interferon signature” in peripheral blood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
Cited by
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.011 · Cited by 470
Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Liu, Z., & Davidson, A. (2012) · Nature Medicine · doi:10.1038/nm.2752 · Cited by 433
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons
Reeves, W. H., Lee, P. Y., Weinstein, J. S., Satoh, M., & Lu, L. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.003 · Cited by 392
Self-citationMurine Models of Systemic Lupus Erythematosus
Perry, D., Sang, A., Yin, Y., Zheng, Y.-Y., & Morel, L. (2011) · BioMed Research International · doi:10.1155/2011/271694 · Cited by 378
An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management
Ameer, M. A., Chaudhry, H., Mushtaq, J., Khan, O. S., Babar, M., Hashim, T., Zeb, S., Tariq, M. A., Patlolla, S. R., Ali, J., et al. (2022) · Cureus · doi:10.7759/cureus.30330 · Cited by 346
Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
Chen, K., Liu, J., & Cao, X. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.03.008 · Cited by 312
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model
Rowland, S. L., Riggs, J. M., Gilfillan, S., Bugatti, M., Vermi, W., Kolbeck, R., Unanue, E. R., Sanjuan, M. A., & Colonna, M. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132620 · Cited by 281
Interferons and Their Stimulated Genes in the Tumor Microenvironment
Cheon, H., Borden, E. C., & Stark, G. R. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.002 · Cited by 255
Regulation of autoreactive B cell responses to endogenous TLR ligands
Avalos, A. M., Busconi, L., & Marshak-Rothstein, A. (2010) · Autoimmunity · doi:10.3109/08916930903374618 · Cited by 114
“However, IFNAR deficiencies were protective in a model of pristane-induced lupus [64] and in the B6.”
BackgroundA BRISC-SHMT Complex Deubiquitinates IFNAR1 and Regulates Interferon Responses
Zheng, H., Gupta, V., Patterson-Fortin, J., Bhattacharya, S., Katlinski, K., Wu, J., Varghese, B., Carbone, C. J., Aressy, B., Fuchs, S. Y., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.025 · Cited by 101
Janus‐like effects of type I interferon in autoimmune diseases
Axtell, R. C., & Raman, C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01131.x · Cited by 47
Metadata
- Authors
- Nacionales, D. C., Kelly‐Scumpia, K. M., Lee, P. Y., Weinstein, J. S., Lyons, R., Sobel, E., Satoh, M., & Reeves, W. H.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-10-29
- Volume
- 56
- Issue
- 11
- Pages
- 3770-3783
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1981866304
- Cited by
- 194
- References
- 1
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.